Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2022

01-04-2022 | Original Article

The bidirectional relationship between metabolic syndrome and hyperuricemia in China: A longitudinal study from CHARLS

Authors: Wen-Yu Chen, Yan-Peng Fu, Min Zhou

Published in: Endocrine | Issue 1/2022

Login to get access

Abstract

Objective

It has been reported that metabolic syndrome (MetS) has been associated with hyperuricemia. However, current findings have been inconclusive regarding the direction of this association. The objective of this study was to clarify the possible directional relationship between hyperuricemia and MetS.

Design

This study used two waves of data from the China Health and Retirement Longitudinal Study (CHARLS) in 2011 and 2015 (N = 6,253, aged ≥40 years). Logistic regression and cross-lagged panel design were performed to evaluate the bidirectional association between uric acid with MetS. MetS score is defined as the number of MetS components present.

Results

New-onset hyperuricemia and MetS were observed in a four-year follow-up study among 719 and 625 participants, respectively. A positive association was observed in the adjusted logistical regression model between baseline MetS score and new-onset hyperuricemia (P for trend <0.001), and also between baseline serum uric acid (SUA) and new-onset MetS (P for trend <0.001). Cross-lagged panel analysis indicated MetS score positively and prospectively predicted SUA, but not vice versa. After stratification by sex, we observed a strong, bidirectional relationship between MetS score and SUA indicating that diagnosis in one illness increased the risk of the other, both men and women. Moreover, this study also found that systolic blood pressure (P < 0.001) and triglycerides (P < 0.001) had a bidirectional relationship with SUA.

Conclusions

The results of this study indicated a bidirectional relationship between MetS and hyperuricemia.
Appendix
Available only for authorised users
Literature
1.
K.G. Alberti et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–5 (2009)CrossRef
2.
R.M. Tanner, T.M. Brown, P. Muntner, Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr. Hypertens. Rep. 14(2), 152–9 (2012)CrossRef
3.
H. Ge et al. The prevalence and associated factors of metabolic syndrome in Chinese aging population. Sci. Rep. 10(1), 20034 (2020)CrossRef
4.
S. O’Neill, L. O’Driscoll, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16(1), 1–12 (2015)CrossRef
5.
M.J. Guembe et al. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 19(1), 195 (2020)CrossRef
6.
S. Mottillo et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 56(14), 1113–32 (2010)CrossRef
7.
D.L. Mendrick et al. Metabolic syndrome and associated diseases: from the bench to the clinic. Toxicol. Sci. 162(1), 36–42 (2018)CrossRef
8.
C.Y. Wei et al. Association between hyperuricemia and metabolic syndrome: an epidemiological study of a labor force population in Taiwan. Biomed. Res Int 2015, 369179 (2015)PubMedPubMedCentral
9.
Z. Liu et al. Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies. Sci. Rep. 5, 14325 (2015)CrossRef
10.
G. Huang et al. Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu. Sci. Rep. 10(1), 8678 (2020)CrossRef
11.
J.H. Liu et al. Metabolic syndrome and 5-year incident hyperuricemia among older chinese adults: a community-based cohort study. Diabetes Metab. Syndr. Obes. 13, 4191–4200 (2020)CrossRef
12.
I. Mortada, Hyperuricemia, Type 2 diabetes mellitus, and hypertension: an emerging association. Curr. Hypertens. Rep. 19(9), 69 (2017)CrossRef
13.
S.K. Cho et al. U-shaped association between serum uric acid level and risk of mortality: a cohort study. Arthritis Rheumatol. 70(7), 1122–1132 (2018)CrossRef
14.
H. Liu et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J. Nephrol. 27(6), 653–8 (2014)CrossRef
15.
K. Nagahama et al. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens. Res 37(3), 232–8 (2014)CrossRef
16.
Y. Zhao et al. Cohort profile: The China Health and Retirement Longitudinal Study (CHARLS). Int J. Epidemiol. 43(1), 61–8 (2014)CrossRef
17.
K.G. Alberti, R.H. Eckel, S.M. Grundy et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009)CrossRef
18.
G. Desideri, G. Castaldo, A. Lombardi et al. Is it time to revise the normal range of serum uric acid levels? Eur. Rev. Med Pharm. Sci. 18(9), 1295–1306 (2014)
19.
A. Laudisio et al. Metabolic syndrome and hemoglobin levels in elderly adults: the Invecchiare in Chianti Study. J. Am. Geriatr. Soc. 61(6), 963–968 (2013)CrossRef
20.
Y. Song, L. Tang, J. Han et al. Uric acid provides protective role in red blood cells by antioxidant defense: a hypothetical analysis. Oxid. Med Cell Longev. 2019, 3435174 (2019)PubMedPubMedCentral
21.
I.Y. Kim et al. Women with metabolic syndrome and general obesity are at a higher risk for significant hyperuricemia compared to men. J Clin Med. 8(6), 806–837 (2019).CrossRef
22.
M. Kanbay et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur. J. Intern Med 29, 3–8 (2016)CrossRef
23.
M. Liu, Y. He, B. Jiang et al. Association between serum uric acid level and metabolic syndrome and its sex difference in a chinese community elderly population. Int J. Endocrinol. 2014, 754678 (2014)PubMedPubMedCentral
24.
Y. Liu, Y. Fan, Q. Liu et al. Sex-specific association of serum uric acid dynamics with the incidence of metabolic syndrome in a health check-up Chinese population: a prospective cohort study. BMJ Open 10(7), e035289 (2020).CrossRef
25.
Y. Tsushima et al. Uric acid secretion from adipose tissue and its increase in obesity. J. Biol. Chem. 288(38), 27138–27149 (2013)CrossRef
26.
M.G. Battelli et al. The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim Biophys. Acta Mol. Basis Dis. 1864(8), 2557–2565 (2018)CrossRef
27.
C. King et al. Uric acid as a cause of the metabolic syndrome. Contrib. Nephrol. 192, 88–102 (2018)CrossRef
28.
R. Buzas et al. Serum uric acid and arterial hypertension-Data from Sephar III survey. PLoS One 13(7), e0199865 (2018)CrossRef
29.
T.Y. Yu et al. The protective effects of increasing serum uric acid level on development of metabolic syndrome. Diabetes Metab. J. 43(4), 504–520 (2019)CrossRef
30.
S. Low et al. Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore. Endocrine 65(1), 73–80 (2019)CrossRef
Metadata
Title
The bidirectional relationship between metabolic syndrome and hyperuricemia in China: A longitudinal study from CHARLS
Authors
Wen-Yu Chen
Yan-Peng Fu
Min Zhou
Publication date
01-04-2022
Publisher
Springer US
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-02979-z

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue

Original Article

Excess branched-chain amino acids alter myotube metabolism and substrate preference which is worsened by concurrent insulin resistance

Original Article

Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions

Review

Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians by the Italian Minimally-Invasive Treatments of the Thyroid group

Research Letter

ACTH-secreting pituitary carcinoma with TP53, NF1, ATRX and PTEN mutations Case report and review of the literature

Original Article

Anti-CD20 therapy ameliorates β cell function and rebalances Th17/Treg cells in NOD mice

Original Article

A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits